Pharmaceutical giant Pfizer has named Patrizia Cavazzoni, a former director at the FDA, as its new chief medical officer, ensuring a seasoned leader oversees its regulatory and drug safety operations. This strategic appointment follows Cavazzoni’s departure from the FDA when she was among many high-profile exits under the Trump administration.
About the Author
